These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9794812)

  • 1. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
    Carlile GW; Tatton WG; Borden KL
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells.
    Kiesslich A; von Mikecz A; Hemmerich P
    J Struct Biol; 2002; 140(1-3):167-79. PubMed ID: 12490165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of PML in p53-dependent apoptosis.
    Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
    Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
    Muratani M; Gerlich D; Janicki SM; Gebhard M; Eils R; Spector DL
    Nat Cell Biol; 2002 Feb; 4(2):106-10. PubMed ID: 11753375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells.
    Liu J; Song Y; Tian B; Qian J; Dong Y; Liu J; Liu B; Sun Z
    J Biochem; 2010 Dec; 148(6):659-67. PubMed ID: 20823370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
    Rasheed ZA; Saleem A; Ravee Y; Pandolfi PP; Rubin EH
    Exp Cell Res; 2002 Jul; 277(2):152-60. PubMed ID: 12083797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
    Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for PML and the nuclear body in genomic stability.
    Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP
    Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
    Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
    EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.